United States
Germany
Japan
United Kingdom
China
Troponin T1 (TNNT1) goat polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Bovine, Canine, Human, Porcine |
Antibodies
POU6F1 goat polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Bovine, Canine, Human, Mouse, Rat |
FABP4 goat polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Canine, Human |
Pex1 goat polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Bovine, Canine, Human, Mouse, Rat |
COMT (N-term) goat polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Canine, Human, Mouse, Rat |
Goat Polyclonal Anti-Rab4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
Goat Polyclonal Anti-REP1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
Canine IgA (Fc specific) goat polyclonal antibody, FITC
| Applications | Can be used in immunocytochemical and immunohistochemical staining of IgA at the cellular and subcellular level of appropriately treated cell and tissue substrates; to demonstrate circulating IgA antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen using a reference antibody of dog origin known to be of the IgA isotype in the middle layer of the indirect test procedure. Antisera to IgA do not discriminate between serum IgA (monomeric and dimeric) and higher molecular forms such as secretory IgA. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/20 and 1/80, depending on the method used. |
| Reactivities | Canine |
| Conjugation | FITC |
Canine IgG (Fc specific) goat polyclonal antibody, FITC
| Applications | Can be used in immunocytochemical and immunohistochemical staining of IgG at the cellular and subcellular level of appropriately treated cell and tissue substrates; to demonstrate circulating IgG antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen using a reference antibody of dog origin known to be of the IgG isotype in the middle layer of the indirect test procedure. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/15 and 1/60, depending on the method used. |
| Reactivities | Canine |
| Conjugation | FITC |
Canine IgM (Fc specific) goat polyclonal antibody, FITC
| Applications | Can be used in Immunocytochemical and Immunohistochemical staining of IgM at the cellular and subcellular level of appropriately treated cell and tissue substrates; to demonstrate circulating IgM antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen using a reference antibody of dog origin known to be of the IgM isotype in the middle layer of the indirect test procedure. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. General Recommended Dilutions: are usually between 1/10 and 1/40, depending on the method used. |
| Reactivities | Canine |
| Conjugation | FITC |
Canine IgG (H+L chain) goat polyclonal antibody, FITC
| Applications | Can be used to identify and measure IgG, antigen or antibody, at the cellular and subcellular level by immunofluorescence staining of appropriately treated cell and tissue substrates, and to demonstrate circulating antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen or immune complex using a reference antibody of dog origin in the middle layer of the indirect test procedure. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/20 and 1/120. |
| Reactivities | Canine |
| Conjugation | FITC |
GABA B Receptor 1 (GABBR1) (947-961) goat polyclonal antibody, Aff - Purified
| Applications | IHC |
| Reactivities | Human, Bovine, Bat, Canine, Equine, Hamster, Monkey, Mouse, Porcine, Rabbit, Rat |
DLGAP1 (391-405) goat polyclonal antibody, Aff - Purified
| Applications | IHC |
| Reactivities | Human, Bovine, Bat, Canine, Equine, Hamster, Mouse, Rabbit, Rat, Xenopus |
Canine IgG1 goat polyclonal antibody, HRP
| Applications | ELISA: 1:10,000 - 1:100,000. Western Blot: 1:1000 - 1:10,000. Immunohistochemistry on frozen sections: 1:200 - 1:500. |
| Reactivities | Canine |
| Conjugation | HRP |
Canine IgE goat polyclonal antibody, Purified
| Applications | ELISA: 1/100-1/10,000. Western Blot: 1/1000-1/10,000. Flow Cytometry: 1/200-1/2,000. This antibody has been reported for use in Immunohistology of Frozen Canine Sections. |
| Reactivities | Canine |
| Conjugation | Unconjugated |
活动过滤器
优化搜索结果
Target Symbol
- RAB27A (5)
- ATAXIN 3 (4)
- CALNEXIN (4)
- CHM (4)
- ERP57 (4)
- GAPDH (4)
- ALPHA TUBULIN (3)
- GJA1 (3)
- RAB11A (3)
- RAB5 (3)
- CATHEPSIN D (2)
- CD19 (2)
- CD45 (2)
- CD63 (2)
- DMTF1 (2)
- E CADHERIN (2)
- EPM2AIP1 (2)
- GAD67 (2)
- GFAP (2)
- HIF-1 ALPHA (2)
- IDH1 (2)
- KCNIP3 (2)
- MAPK9 (2)
- MAPKAPK5 (2)
- P53 (2)
- POU2AF1 (2)
- POU2F2 (2)
- PSMB4 (2)
- RAB14 (2)
- RAB1B (2)
- RAB9A (2)
- ROBO1 (2)
- UCHL1 (2)
- ACADVL (1)
- ACTIVIN RECEPTOR TYPE IA (1)
- AGRP (1)
- AIRE (1)
- ALBUMIN (1)
- ALDH5A1 (1)
- ALDH6A1 (1)
- ANNEXIN A1 (1)
- AP3D1 (1)
- APG12 (1)
- APOLIPOPROTEIN H (1)
- APP (1)
- ATF6 (1)
- AXIN1 (1)
- BAG5 (1)
- BAG6 (1)
- BAX (1)
- BBS4 (1)
- BBS7 (1)
- BCOR (1)
- BEND5 (1)
- BETA ACTIN (1)
- BETA CATENIN (1)
- BLBP (1)
- BMI1 (1)
- BTBD7 (1)
- C-MYB (1)
- C-PEPTIDE (1)
- C3 (1)
- CADM1 (1)
- CATALASE (1)
- CAVEOLIN 1 (1)
- CAVEOLIN 2 (1)
- CCDC3 (1)
- CCNDBP1 (1)
- CD2 (1)
- CD31 (1)
- CD4 (1)
- CDH11 (1)
- CDKAL1 (1)
- CEBPB (1)
- CEBPZ (1)
- CHCHD3 (1)
- CHN2 (1)
- CIRBP (1)
- CKM (1)
- CLUSTERIN (1)
- CNTN4 (1)
- COMT (1)
- CRHR1 (1)
- CRISP2 (1)
- CROT (1)
- CRTC2 (1)
- CSF1R (1)
- CTDSP1 (1)
- CYB5R3 (1)
- CYBRD1 (1)
- CYTOCHROME P450 26B (1)
- DAP12 (1)
- DESI2 (1)
- DGAT1 (1)
- DIXDC1 (1)
- DKK1 (1)
- DLGAP1 (1)
- DPM3 (1)
- EEA1 (1)
- EEF1A2 (1)
Applications
Conjugates
Isotypes
Clonalities
Assay Types
Families
- Druggable Genome (136)
- Transmembrane (43)
- Transcription Factors (27)
- ES Cell Differentiation/IPS (23)
- Secreted Protein (15)
- Stem cell - Pluripotency (6)
- Protease (5)
- Protein Kinase (5)
- Phosphatase (4)
- Adult stem cells (3)
- Ion Channels: Other (3)
- Stem cell relevant signaling - JAK/STAT signaling pathway (3)
- GPCR (2)
- Induced pluripotent stem cells (2)
- Ion Channels: Cys-loop Receptors (2)
- Ion Channels: Potassium (2)
- Ion Channels: Transient receptor potential (2)
- Nuclear Hormone Receptor (2)
- Cancer stem cells (1)
- Embryonic stem cells (1)
- P450 (1)
Pathways
- Pathways in cancer (16)
- Endocytosis (14)
- Metabolic pathways (12)
- Antigen processing and presentation (9)
- Cell adhesion molecules (CAMs) (9)
- Focal adhesion (9)
- Gap junction (9)
- Adherens junction (8)
- Amyotrophic lateral sclerosis (ALS) (8)
- Bladder cancer (8)
- Endometrial cancer (8)
- Pathogenic Escherichia coli infection (8)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (7)
- Cytokine-cytokine receptor interaction (7)
- Calcium signaling pathway (6)
- Prostate cancer (6)
- T cell receptor signaling pathway (6)
- Wnt signaling pathway (6)
- Alzheimer's disease (5)
- Colorectal cancer (5)
- Hematopoietic cell lineage (5)
- MAPK signaling pathway (5)
- Melanoma (5)
- Non-small cell lung cancer (5)
- Pancreatic cancer (5)
- Primary immunodeficiency (5)
- Thyroid cancer (5)
- Type I diabetes mellitus (5)
- mTOR signaling pathway (5)
- Alanine (4)
- Apoptosis (4)
- Basal cell carcinoma (4)
- Glycolysis / Gluconeogenesis (4)
- Huntington's disease (4)
- Insulin signaling pathway (4)
- Lysosome (4)
- Neurotrophin signaling pathway (4)
- Renal cell carcinoma (4)
- aspartate and glutamate metabolism (4)
- p53 signaling pathway (4)
- Allograft rejection (3)
- B cell receptor signaling pathway (3)
- Butanoate metabolism (3)
- Cell cycle (3)
- Dilated cardiomyopathy (3)
- Glioma (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Jak-STAT signaling pathway (3)
- Leukocyte transendothelial migration (3)
- Maturity onset diabetes of the young (3)
- Natural killer cell mediated cytotoxicity (3)
- Neuroactive ligand-receptor interaction (3)
- PPAR signaling pathway (3)
- RIG-I-like receptor signaling pathway (3)
- Regulation of actin cytoskeleton (3)
- Ribosome (3)
- Small cell lung cancer (3)
- TGF-beta signaling pathway (3)
- Tight junction (3)
- Type II diabetes mellitus (3)
- VEGF signaling pathway (3)
- Vibrio cholerae infection (3)
- Acute myeloid leukemia (2)
- Adipocytokine signaling pathway (2)
- Asthma (2)
- Axon guidance (2)
- Chronic myeloid leukemia (2)
- Citrate cycle (TCA cycle) (2)
- Epithelial cell signaling in Helicobacter pylori infection (2)
- ErbB signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- GnRH signaling pathway (2)
- Melanogenesis (2)
- Oocyte meiosis (2)
- Proteasome (2)
- Regulation of autophagy (2)
- Systemic lupus erythematosus (2)
- Taurine and hypotaurine metabolism (2)
- Toll-like receptor signaling pathway (2)
- Ubiquitin mediated proteolysis (2)
- Viral myocarditis (2)
- beta-Alanine metabolism (2)
- Arachidonic acid metabolism (1)
- Arginine and proline metabolism (1)
- Autoimmune thyroid disease (1)
- Base excision repair (1)
- Chemokine signaling pathway (1)
- D-Glutamine and D-glutamate metabolism (1)
- Dorso-ventral axis formation (1)
- ECM-receptor interaction (1)
- Ether lipid metabolism (1)
- Fc epsilon RI signaling pathway (1)
- Glutathione metabolism (1)
- Graft-versus-host disease (1)
- Hedgehog signaling pathway (1)
- Histidine metabolism (1)
- Long-term depression (1)
- Long-term potentiation (1)
- Methane metabolism (1)
- NOD-like receptor signaling pathway (1)
- Nitrogen metabolism (1)
- One carbon pool by folate (1)
- Parkinson's disease (1)
- Phosphatidylinositol signaling system (1)
- Porphyrin and chlorophyll metabolism (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Pyrimidine metabolism (1)
- Pyruvate metabolism (1)
- Retinol metabolism (1)
- SNARE interactions in vesicular transport (1)
- Spliceosome (1)
- Tryptophan metabolism (1)
- Vascular smooth muscle contraction (1)
